Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.5330
-0.0130 (-2.38%)
At close: Aug 12, 2026, 4:00 PM EDT
0.5500
+0.0170 (3.19%)
After-hours: Aug 12, 2026, 4:02 PM EDT
Mangoceuticals Revenue
Mangoceuticals had revenue of $67.86K in the quarter ending March 31, 2026, a decrease of -37.91%. This brings the company's revenue in the last twelve months to $414.58K, down -18.88% year-over-year. In the year 2025, Mangoceuticals had annual revenue of $456.02K, down -25.96%.
Revenue (ttm)
$414.58K
Revenue Growth
-18.88%
P/S Ratio
22.61
Revenue / Employee
$138,193
Employees
3
Market Cap
9.28M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 456.02K | -159.85K | -25.96% |
| Dec 31, 2024 | 615.87K | -115.62K | -15.81% |
| Dec 31, 2023 | 731.49K | 722.55K | 8,083.16% |
| Dec 31, 2022 | 8.94K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Definitive Healthcare | 232.70M |
| CareCloud | 128.64M |
| OptimizeRx | 107.35M |
| DarioHealth | 21.19M |
| Healthcare Triangle | 20.04M |
| Zhongchao | 11.37M |
| Mobile-health Network Solutions | 7.32M |
| OneMedNet | 1.32M |
MGRX News
- 6 days ago - Mangoceuticals’ partner Nuclea signs MOU with New Mining on reactor - TheFly
- 6 days ago - Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - GlobeNewsWire
- 6 days ago - Nuclea Energy Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - Newsfile Corp
- 7 days ago - Mangoceuticals' Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - GlobeNewsWire
- 7 days ago - Nuclea Energy USA Inc. Announces MOU with Utah Office of Energy Development - Newsfile Corp
- 8 days ago - Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - GlobeNewsWire
- 13 days ago - Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - Newsfile Corp
- 13 days ago - Mangoceuticals enters business combination agreement with Nuclea Energy - TheFly